Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder
The selective serotonin reuptake inhibitor escitalopram (ESC) is indicated for the treatment of major depressive disorder (MDD) and of generalized anxiety disorder (GAD). Monitoring of blood levels (BLs) is strongly indicated due to ESC’s high interindividual pharmacokinetic variability. The aim of...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 2023
|
| In: |
European archives of psychiatry and clinical neuroscience
Year: 2023, Jahrgang: 273, Heft: 1, Pages: 75-83 |
| ISSN: | 1433-8491 |
| DOI: | 10.1007/s00406-022-01491-9 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00406-022-01491-9 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00406-022-01491-9 
|
| Verfasserangaben: | X.M. Hart, S. Heesen, C.N. Schmitz, S. Dörfler, D. Wedekind, G. Gründer, C. Hiemke, U. Havemann-Reinecke |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1892138026 | ||
| 003 | DE-627 | ||
| 005 | 20241205144052.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240625s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00406-022-01491-9 |2 doi | |
| 035 | |a (DE-627)1892138026 | ||
| 035 | |a (DE-599)KXP1892138026 | ||
| 035 | |a (OCoLC)1475300599 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hart, Xenia Marlene |d 1994- |e VerfasserIn |0 (DE-588)1248335058 |0 (DE-627)1783559357 |4 aut | |
| 245 | 1 | 0 | |a Concentrations of escitalopram in blood of patients treated in a naturalistic setting |b focus on patients with alcohol and benzodiazepine use disorder |c X.M. Hart, S. Heesen, C.N. Schmitz, S. Dörfler, D. Wedekind, G. Gründer, C. Hiemke, U. Havemann-Reinecke |
| 264 | 1 | |c February 2023 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 7. Oktober 2022 | ||
| 500 | |a Gesehen am 25.06.2024 | ||
| 520 | |a The selective serotonin reuptake inhibitor escitalopram (ESC) is indicated for the treatment of major depressive disorder (MDD) and of generalized anxiety disorder (GAD). Monitoring of blood levels (BLs) is strongly indicated due to ESC’s high interindividual pharmacokinetic variability. The aim of this study was to analyse clinical efficacy and pharmacokinetic influences on ESC BLs, in patients with depressive disorder alone and with comorbid alcohol or benzodiazepine use disorder. Data were collected from patients treated under naturalistic conditions for whom Therapeutic Drug Monitoring (TDM) was requested to guide antidepressant drug therapy and analysed retrospectively. Particular emphasis was given to patients with alcohol or benzodiazepine use disorder. Responders according to the clinical global impression (CGI) scale were compared with nonresponders for their ESC blood level (BL). The patient sample included 344 patients from 16 psychiatric hospitals in Germany. Influencing factors that could explain 22% of ESC BLs were dose, sex and age. Variability was high between individuals, and doses up to 40 mg were common in real-world settings. Patients treated with ESC monotherapy who responded showed a trend towards higher BLs compared to nonresponders with a concentration of 15 ng/mL separating both groups. Pathological changes in liver function (indicated by elevated GGT in combination with an AST/ALT ratio ≥ 1) resulted in higher dose-corrected ESC concentrations. Influencing factors that could explain 22% of ESC blood levels were dose, sex, and age. Our findings confirm the currently recommended lower threshold level and support the need for standard TDM analyses in everyday clinical practice. The ICD 10 diagnosis alcohol dependence alone does not lead to pharmacokinetic changes in the metabolism of ESC, but altered liver function does. | ||
| 650 | 4 | |a Alcohol use disorder | |
| 650 | 4 | |a Benzodiazepine use disorder | |
| 650 | 4 | |a Depression | |
| 650 | 4 | |a Depressive disorder | |
| 650 | 4 | |a Escitalopram | |
| 650 | 4 | |a Pharmacokinetics | |
| 650 | 4 | |a SSRI | |
| 700 | 1 | |a Heesen, Sebastian H. |e VerfasserIn |0 (DE-588)1330984749 |0 (DE-627)1890133930 |4 aut | |
| 700 | 1 | |a Schmitz, Christian N. |d 1992- |e VerfasserIn |0 (DE-588)1323761616 |0 (DE-627)1883715016 |4 aut | |
| 700 | 1 | |a Dörfler, Sebastian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wedekind, Dirk |d 1969- |e VerfasserIn |0 (DE-588)123654297 |0 (DE-627)082687544 |0 (DE-576)293810141 |4 aut | |
| 700 | 1 | |a Gründer, Gerhard |e VerfasserIn |0 (DE-588)1078251037 |0 (DE-627)838195350 |0 (DE-576)449927644 |4 aut | |
| 700 | 1 | |a Hiemke, Christoph |d 1948- |e VerfasserIn |0 (DE-588)1145417272 |0 (DE-627)1006549528 |0 (DE-576)161418430 |4 aut | |
| 700 | 1 | |a Havemann-Reinecke, Ursula |d 1950- |e VerfasserIn |0 (DE-588)120873117 |0 (DE-627)080939953 |0 (DE-576)292425503 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European archives of psychiatry and clinical neuroscience |d Darmstadt : Steinkopff, 1868 |g 273(2023), 1 vom: Feb., Seite 75-83 |h Online-Ressource |w (DE-627)253722691 |w (DE-600)1459045-1 |w (DE-576)072372559 |x 1433-8491 |7 nnas |a Concentrations of escitalopram in blood of patients treated in a naturalistic setting focus on patients with alcohol and benzodiazepine use disorder |
| 773 | 1 | 8 | |g volume:273 |g year:2023 |g number:1 |g month:02 |g pages:75-83 |g extent:9 |a Concentrations of escitalopram in blood of patients treated in a naturalistic setting focus on patients with alcohol and benzodiazepine use disorder |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00406-022-01491-9 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00406-022-01491-9 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20240625 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 1078251037 |a Gründer, Gerhard |m 1078251037:Gründer, Gerhard |d 60000 |e 60000PG1078251037 |k 0/60000/ |p 6 | ||
| 998 | |g 1323761616 |a Schmitz, Christian N. |m 1323761616:Schmitz, Christian N. |d 60000 |e 60000PS1323761616 |k 0/60000/ |p 3 | ||
| 998 | |g 1248335058 |a Hart, Xenia Marlene |m 1248335058:Hart, Xenia Marlene |d 60000 |e 60000PH1248335058 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1892138026 |e 4541483920 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"subtitle":"focus on patients with alcohol and benzodiazepine use disorder","title":"Concentrations of escitalopram in blood of patients treated in a naturalistic setting","title_sort":"Concentrations of escitalopram in blood of patients treated in a naturalistic setting"}],"language":["eng"],"person":[{"family":"Hart","display":"Hart, Xenia Marlene","given":"Xenia Marlene","role":"aut"},{"family":"Heesen","display":"Heesen, Sebastian H.","role":"aut","given":"Sebastian H."},{"family":"Schmitz","role":"aut","given":"Christian N.","display":"Schmitz, Christian N."},{"family":"Dörfler","display":"Dörfler, Sebastian","given":"Sebastian","role":"aut"},{"display":"Wedekind, Dirk","role":"aut","given":"Dirk","family":"Wedekind"},{"display":"Gründer, Gerhard","given":"Gerhard","role":"aut","family":"Gründer"},{"display":"Hiemke, Christoph","role":"aut","given":"Christoph","family":"Hiemke"},{"display":"Havemann-Reinecke, Ursula","role":"aut","given":"Ursula","family":"Havemann-Reinecke"}],"name":{"displayForm":["X.M. Hart, S. Heesen, C.N. Schmitz, S. Dörfler, D. Wedekind, G. Gründer, C. Hiemke, U. Havemann-Reinecke"]},"id":{"eki":["1892138026"],"doi":["10.1007/s00406-022-01491-9"]},"physDesc":[{"extent":"9 S."}],"note":["Online veröffentlicht: 7. Oktober 2022","Gesehen am 25.06.2024"],"relHost":[{"recId":"253722691","origin":[{"dateIssuedDisp":"1868-","publisher":"Steinkopff ; Springer","dateIssuedKey":"1868","publisherPlace":"Darmstadt ; Berlin ; Heidelberg"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Psychiatry and clinical neuroscience"},{"title":"Archiv für Psychiatrie und Nervenkrankheiten"},{"title":"European archives of psychiatry and neurological sciences"}],"note":["Zusatz teils: official organ of the German Society for Biological Psychiatry","Ungezählte Beil.: Supplement"],"disp":"Concentrations of escitalopram in blood of patients treated in a naturalistic setting focus on patients with alcohol and benzodiazepine use disorderEuropean archives of psychiatry and clinical neuroscience","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["253722691"],"issn":["1433-8491"],"zdb":["1459045-1"]},"pubHistory":["1.1868/69 -"],"language":["eng"],"part":{"volume":"273","text":"273(2023), 1 vom: Feb., Seite 75-83","year":"2023","issue":"1","extent":"9","pages":"75-83"},"title":[{"title":"European archives of psychiatry and clinical neuroscience","title_sort":"European archives of psychiatry and clinical neuroscience"}]}],"recId":"1892138026","origin":[{"dateIssuedDisp":"February 2023","dateIssuedKey":"2023"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a HARTXENIAMCONCENTRAT2023 | ||